Anwita Khaitan, Shivam Kapoor, Amit Yadav, Chandravali Madan
Brand extension and surrogate marketing have sustained tobacco brand visibility within the current regulatory framework. Enforcing COTPA and WHO-FCTC Article 13 with more transparent oversight of corporate diversification may effectively restrict tobacco advertising, promotion, and sponsorship and strengthen NCD prevention.
BACKGROUND: India has established a strong policy framework to curb tobacco use-a significant risk factor for noncommunicable diseases (NCDs)-by enforcing Cigarettes and Other Tobacco Products Act (COTPA) 2003 and ratifying WHO-Framework Convention on Tobacco Control (WHO-FCTC) 2003. Within this regulatory context, India's tobacco companies have diversified business activities and adopted brand extension and other promotional strategies. This exploratory study examines these diversification and surrogate marketing practices and their relevance to tobacco control policy implementation and NCD prevention in India.
METHODOLOGY: A historical review and secondary data analysis were conducted using company reports, academic literature, and industry sources. Six tobacco companies-ITC Limited, Godfrey Phillips India Ltd. (GPI), DS Group, Pataka, Miraj, and Mangalore Ganesh Beedi Works-were analyzed for diversification timelines, brand strategies, and regulatory responses. Qualitative analyses and time-series mapping were undertaken.
RESULTS: ITC Limited emphasized brand stretching using its Wills ® brand (Wills ® Lifestyle, Wills® India Fashion Week), while GPI used its Red and White ® brand (Red and White ® Bravery Awards). DS Group diversified into fast-moving consumer goods (FMCG) and hospitality, with Rajnigandha ® as its flagship brand. Pataka and Miraj expanded into pan masala and FMCG sectors. Ganesh Beedi, however, remained tobacco-centric, relying on scale and cultural imagery. These strategies circumvented COTPA's advertising restrictions and contravened WHO-FCTC Article 13.
CONCLUSIONS: Brand extension and surrogate marketing have sustained tobacco brand visibility within the current regulatory framework. Enforcing COTPA and WHO-FCTC Article 13 with more transparent oversight of corporate diversification may effectively restrict tobacco advertising, promotion, and sponsorship and strengthen NCD prevention.